Frank Moriarty
frankmoriarty.bsky.social
Frank Moriarty
@frankmoriarty.bsky.social
Associate professor, researcher and pharmacist at the School of Pharmacy and Biomolecular Sciences, RCSI. Interested in pharmacoepi, deprescribing, and open research.
This role would be a good fit for an experienced postdoctoral researcher interested in deprescribing, medication appropriateness, and healthcare data.

@deprescribing.bsky.social @deprescribeus.bsky.social @caden-recad.bsky.social
June 27, 2025 at 9:28 AM
We work on developing methods to better support research on deprescribing and to ultimately improve medicines optimisation.

You can find out more about the DIAMOND research programme on our website or LinkedIn profile:
diamond-deprescribing.eu
www.linkedin.com/company/diamond-derx/
Home
DIAMOND is an ambitious Wellcome-funded programme of research that aims to develop and advance novel methods for researching deprescribing by harnessing big data.
diamond-deprescribing.eu
June 23, 2025 at 2:16 PM
Reposted by Frank Moriarty
Many thanks to the other study team members @shellflood.bsky.social, Ciara Kirke, Molly Mattsson, @marywalsh14.bsky.social, @profemmawallace.bsky.social, Derek Corrigan, Tom Fahey, and Fiona Boland.
March 14, 2025 at 11:30 AM
RxTrends uses data released by the Primary Care Reimbursement Service on the top 100 medicines per month for the GMS (medical card) scheme. We are hoping to expand the functionality more in the future, however this needs more #opendata to be made available.
March 14, 2025 at 11:30 AM
Huge congratulations Dr Hughes! Enjoy the celebrations.
December 16, 2024 at 6:40 PM
A bit late to the game!
November 11, 2024 at 10:08 PM